Amanote Research

Amanote Research

    RegisterSign In

The Revised Who Classification of Myelodysplastic Syndromes – What Has Changed?

Pathology - United States
doi 10.1016/j.pathol.2020.01.142
Full Text
Open PDF
Abstract

Available in full text

Categories
Forensic MedicinePathology
Date

February 1, 2020

Authors
Gina Zini
Publisher

Elsevier BV


Related search

The Revised Who Classification of Myeloproliferative Neoplasms – What Has Changed?

Pathology
Forensic MedicinePathology
2020English

Validation of and Proposals for Refinements of the WHO 2016 Classification for Myelodysplastic Syndromes

American Journal of Hematology
Hematology
2017English

Erratum To: Rheumatoid Arthritis: What Has Changed?

Skeletal Radiology
Nuclear MedicineRadiologyImaging
2010English

The Myelodysplastic Syndromes

Emerging Cancer Therapeutics
2011English

The Myelodysplastic Syndromes

Oncologist
Cancer ResearchMedicineOncology
1997English

Fuelwood Revisited: What Has Changed in the Last Decade?

2003English

What Has Changed in the Structure of Revision Hip Arthroplasty?

Traumatology and Orthopedics of Russia
2019English

Myelodysplastic Syndromes

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2011English

Myelodysplastic Syndromes

Cancer
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy